A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
Clinical trial NCT00191373 · COMPLETED
Trial details
- NCT number
- NCT00191373
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.